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Abstract
Background: Anoxic coma following cardiac arrest is a common problem with ethical, social, and legal
consequences. Except for unfavorable somatosensory-evoked potentials (SSEP) results, predictors of
unfavorable outcome with a 100% specificity and a high sensitivity are lacking. The aim of the current
research was to construct a clinical and EEG scoring system that predicts early cortical response (N20) to
somatosensory evoked potentials and 6-months outcome in comatose patients after cardiac arrest.
Methods: We retrospectively reviewed the records of all consecutive patients who suffered cardiac
arrest outside our hospital and were subsequently admitted to our facility from November 2002 to July
2006. We scored each case based on early clinical and EEG factors associated with unfavorable SSEPs, and
we assessed the ability of this score to predict SSEP results and outcome.
Results: Sixty-six patients qualified for inclusion in the cohort. Among them, 34 (52%) had unfavorable
SSEP results. At day three, factors independently associated with unfavorable SSEPs were: absence of
corneal (14 points) and pupillary (21 points) reflexes, myoclonus (25 points), extensor or absent motor
response to painful stimulation (28 points), and malignant EEG (11 points). A score >40 points had a
sensitivity of 85%, a specificity of 84%, and a positive predictive value (PPV) of 85% to predict unfavorable
SSEP results. A score >88 points had a PPV of 100%, but a sensitivity of 18%. Overall, this score had an
area under ROC curves of 0.919. In addition, at day three, a score > 69 points had a PPV of 100% with a
sensitivity of 32% to predict death or vegetative state.
Conclusion: A scoring system based on a combination of clinical and EEG findings can predict the absence
of early cortical response to SSEPs. In settings without access to SSEPs, this score may help decision-
making in a subset of comatose survivors after a cardiac arrest.
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Background
Despite improvements in cardiopulmonary resuscitation,
56% to 90% of patients who remain comatose after car-
diac arrest have a poor outcome (death or permanent veg-
etative state) [1]. For this reason, intensive care physicians
are confronted with the ethical question of whether to
continue treatment. In this context, early predictors of
poor outcome would be valuable.
In the last few decades, several clinical and electrophysio-
logical variables have been reported to be strongly associ-
ated with a poor outcome in comatose survivors of cardiac
arrest; these include absence of pupillary and corneal
reflexes, absent motor response to pain [2-5], myoclonus
or epilepticus status [6,7], an increase of neuron specific
enolase (NSE) in serum [8], and a burst-suppression or
isoelectric electro-encephalography (EEG) pattern
[7,9,10]. However, in most cases, evidence predictive of
poor outcome remains to be determined [1,8,11].
In contrast, bilateral absence of early cortical responses to
somatosensory evoked potentials (SSEPs) demonstrated a
100% specificity for predicting poor outcome in this pop-
ulation [1,5,8,12-17], but this electrophysiological proce-
dure is not routinely performed in all ICUs. For example,
in a systematic review of early prediction of poor outcome
in anoxic-ischaemic coma, the prognostic value of SSEPs
was studied in only 11 out of 33 studies (33%) [1]. There-
fore, alternatives are needed in settings without SSEPs.
We identified risk factors associated with unfavorable
SSEP results; and based on these risk factors, we computed
an early clinical and EEG score and assessed its predictive
value, sensitivity, and specificity for predicting unfavora-
ble SSEP results. Finally, we assessed the value of this score
for predicting poor neurological outcomes in this patient
population.
Methods
Patients
We conducted a retrospective cohort study of all consecu-
tive patients who had suffered cardiac arrest outside the
hospital and were subsequently admitted to the adult
intensive care unit in the Caen University Hospital from
November 2002 to July 2006. Patients who died or awoke
within the first three days of admission were excluded
from this analysis.
Data collection
The institutional review board was consulted and consid-
ered that this protocol did not require Ethical approval
given the observational and non-interventional nature of
the study investigating routine care. Clinical variables col-
lected at baseline were: age, sex, medical history (cardiovas-
cular, respiratory, neurologic, metabolic diseases), cause of
the arrest (cardiac, respiratory, other or unknown), time
between arrest and cardiopulmonary resuscitation (<3
min, 3–5 min, >5 min), cardiac rhythm before cardiopul-
monary resuscitation (ventricular fibrillation or tachycar-
dia, asystole, pulseless rhythm), duration of
cardiopulmonary resuscitation (<5 min, 5–15 min, >15
min), and scoring of disease severity within the first day in
ICU as assessed by admission Simplified Acute Physiology
Score type II (SAPS II) [18] and Acute Physiology and
Chronic Health Evaluation (APACHE) II score [19].
Clinical procedures performed at days one and three were:
pupillary light reflex (present/absent), motor response to
painful stimulation (extensor or absent response/other
response), corneal reflex (present/absent), tonic-clonic
seizures (present/absent) and myoclonus (present/
absent).
Electrophysiological assessment
EEG and SSEPs were routinely performed in our center. For
the purpose of this study, a neurophysiologist expert (O.E.)
retrospectively reviewed all EEGs to allow similar definitions
and increase homogeneity of the material. He was blinded to
the clinical features at the time of recordings and to the out-
come. EEG was recorded on at least a 10-channels system
with needle electrodes using 10–20 international system
(Fp1, Fp2, C3, C4, T5, T6, O1, and O2). The EEG patterns
were classified at day one and day three according to the clas-
sification system of Synek et al [20,21] [see Additional file 1].
EEG results were dichotomized as malignant and non-malig-
nant, including benign and uncertain patterns. SSEPs were
systematically performed the third day after cardiac resuscita-
tion. However, if SSEPs recording was due on a weekend day,
the recording was postponed to Monday. SSEps were
recorded on Nicolet Viking IV using 6 channels: erb'point;
C6sp; C'3 or C'4 controlateral to the stimulated hand and
Fpz (ipsilateral ear was used as reference). The two remaining
channels served as channels control: C'3 – C'4 (or C'3–C'4)
on which N20 amplitude was measured and Fpz-C'3 (or
Fpz-C'4) in order to check for long-latency component using
larger time-window. Absence of early cortical responses to
somatosensory evoked potentials were asserted only if the 3
following conditions were present: (i) correct peripheral
(N10) and medullar (N13) component, (ii) no deflexion
higher than 0.5 μV on C3–C'4 (or C'3–C'4) (iii) no late com-
ponent on Fpz-C'3 (or Fpz-C'4). Two groups of patients were
defined for statistical analysis according to SSEP results:
Group 1, patients with bilateral absence of early cortical
responses (unfavorable result of SSEPs) and Group 2,
patients with uni- or bilateral presence of early cortical
responses (favorable result of SSEPs).
Assessment of outcome
Neurological status at six months after cardiac arrest was
recorded using the five grade Glasgow-Pittsburgh CerebralBMC Cardiovascular Disorders 2008, 8:35 http://www.biomedcentral.com/1471-2261/8/35
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Performance Category (GP-CPC) scale [22] [see Addi-
tional file 2]. Neurological outcome was classified as favo-
rable (GP-CPC 1, 2, and 3) and unfavorable (GP-CPC 4
and 5).
Treatment and treatment restriction
All patients were treated without restriction for the first
three days following cardiac arrest. They received standard
intensive care management and monitoring, including
induced hypothermia as recommended [23,24]. Propo-
fol, midazolam and sufentanyl were used as standard sed-
ative and were stopped shortly before clinical assessment
and EEG recording when this was possible. Hypothermia
was induced using a endovascular cooling catheter (Icy™,
Alsius, Irvine, CA, USA), inserted in the inferior vena cava
via the femoral vein and connected to a cooling device
(Coolgard 3000™, Alsius, Irvine, CA, USA), and was main-
tained during 24 hours. For patients which underwent
cooling after resuscitation, clinical variables and neuro-
physiological tests were performed after rewarning. In our
practice, bilateral lack of cortical response to SSEPs leads
to active care withdrawal.
Statistical analysis
Quantitative variables were expressed as means ± standard
deviation (SD) with their 95% confidence intervals (CI).
Qualitative variables were expressed as percentages with
their 95% CIs.
All analyses were replicated for day one and day three var-
iables. Firstly, we investigated the univariate associations
between clinical and EEG results (predictors) and out-
comes (pejorative results of SSEPs and 6-month poor neu-
rological outcome) using Fisher exact tests. Secondly, we
constructed a multivariable model predicting the proba-
bility of outcome by performing a backward logistic
regression that included variables associated at p < 0.25 in
univariate analysis. Thirdly, we computed a score, based
on the point system developed by Sullivan [25], using the
beta coefficients of all risk factors that were significantly
associated with outcomes in the multivariable analysis.
The beta coefficients were multiplied by 10 to round them
to the nearest integer and then were summed. Fourthly,
we plotted Receiver Operating Characteristics (ROC)
curves to estimate the capacity of the score to predict out-
come using the Area Under Curve (c-index), sensitivity
(Se) and specificity (Sp). We used SPSS 14.0 (Chicago, IL)
for data analysis. All tests were two-sided and a p-value <
0.05 was considered statistically significant.
Results
Baseline characteristics and neurological outcome
Of the 109 consecutive patients resuscitated after a cardiac
arrest outside the hospital and admitted to our intensive
care unit during the study period, 66 fulfilled inclusion
criteria for analysis: 34 (52%) in group 1 (unfavorable
result of SSEPs) and 32 (48%) in group 2 (favorable result
of SSEPs), as shown in Figure 1. Patient baseline charac-
teristics are presented in Table 1. Fifteen patients (22%)
underwent cooling after resuscitation (6 in group 1 and 9
in group 2). Only asystole as cardiac rhythm before CPR
(odds ratio [OR] = 0.3; 95% CI = 0.1–1; p = 0.04), and
duration of CPR > 15 min (OR = 0.3; 95% CI = 0.1–0.9; p
= 0.03) were significantly associated with group 1. The
neurological outcome at six months was favorable in 13
(20%) patients, all in group 2 (Figure 1).
Predictors of unfavorable result of SSEPs
In univariate analysis (Table 2), absence of corneal and
pupillary reflexes, myoclonus, and extensor or absent
motor response to painful stimulation was significantly
associated with group 1 at day one and day three. A malig-
nant EEG was also significantly associated with group 1 at
day three. In multivariate logistic-regression analysis
(Table 2), absence of corneal reflex, myoclonus, extensor
or absent motor response to painful stimulation were
independently associated with a unfavorable result of
SSEPs, at both day one and day three. In addition, absence
of pupillary reflex and a malignant EEG were also inde-
pendently associated with group 1 at day three.
Score predictive of unfavorable result of SSEPs
At days one and three, the prediction models included
three and five variables, respectively: myoclonus (30
points), extensor or absent motor responses to painful
stimulation (17 points), and absence of corneal reflex (10
points) for day one, and extensor or absent motor
responses to pain (28 points), myoclonus (25 points),
absence of pupillary (21 points) and corneal (14 points)
reflexes, and a malignant EEG (11 points) for day three.
As shown in Figures 2a and 2b respectively, the ROC
curves for unfavorable result of SSEPs indicated a score ≥
88.5 points with a positive predictive value of 100% and
a sensitivity of 18% (95% CI = 8–27) at day three, but
failed to determine a score with a positive predictive value
of 100% at day one. The scores with the highest specificity
and sensitivity were ≥ 28.5 points (day one; Sp = 75%
[95% CI = 65–85], Se = 88% [95% CI = 80–96]) and ≥
40.5 points (day three; Sp = 84% [95% CI = 76–93], Se =
85% [95% CI = 77–94]), with a positive predictive value
of 79% and 85%, respectively. At days one and three,
these scores predicted absence of early cortical responses
to SSEPs with a false positive rate of 21% (day one) and
15% (day three).
Score predictive of unfavorable outcome (GP-CPC 4 or 5)
As shown Figures 3a and 3b, the ROC curves for unfavo-
rable outcome determined a score ≥ 52 points at day one
and a score ≥ 69 points at day three, with a positive pre-
dictive value of 100% and a sensitivity of 35.8% (95% CI
= 24–47) and 32% (95%CI = 21–43), respectively. AnBMC Cardiovascular Disorders 2008, 8:35 http://www.biomedcentral.com/1471-2261/8/35
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unfavorable outcome was predicted in more than a quar-
ter of the studied population with no false positives. The
scores with the highest specificity and sensitivity were ≥ 22
points (day one; Sp = 92% [95% CI = 86–99], Se = 79%
[95% CI = 70–89]) and ≥ 32 points (day three; Sp = 85%
[95% CI = 76–93], Se = 85% [95% CI = 76–94]) with a
positive predictive value of 98% and 96%, respectively.
The presence of two or more predictors at day one or day
three predicted an unfavorable outcome with a false posi-
tive rate of 2% and 4%, respectively.
Contribution of the score to predict the outcome among 
subjects with a favorable result of SSEPs
Among 32 patients with a favorable result of SSEPs, 19
patients had an unfavorable neurological outcome at six
months (Figure 1). As shown in Figure 4, the scoring sys-
tem with 100% specificity at day one (score ≥ 52 points)
and at day three (score ≥ 69 points) predicted death or
vegetative state in two and one patients, respectively. At
day three, the score (≥ 32 points) with the highest sensi-
Table 1: Baseline characteristics of patients (n = 66).
Characteristics
Age (years) 57,2 +/- 12,8
Sex ratio:% male 77%
SAPS II 63 +/- 15
APACHE II 26 +/- 7
Medical History
Cardiovascular diseases n (%) 28 (42)
Neurologic diseases n (%) 5 (8)
Respiratory diseases n (%) 4 (6)
Metabolic diseases n (%) 11 (17)
Primary cause of arrest
Cardiac n (%) 39 (59)
Pulmonary n (%) 16 (24)
Other or unknown n (%)# 11 (17)
Time between arrest and initiation of CPR initiation of CPC
< 3 minutes n (%) 15 (23)
> 3 and < 5 minutes n (%) 5 (8)
> 5 minutes n (%) 34 (52)
Unknown n (%) 12 (18)
Primary rhythm
Ventricular fibrillation n (%) 19 (29)
Ventricular tachycardia n (%) 3 (5)
Asystole n (%) 28 (42)
Unknown n (%) 16 (24)
Duration of CPR
< 5 minutes n (%) 8 (12)
> 5 and < 15 minutes n (%) 22 (33)
> 15 minutes n (%) 31 (47)
Unknown n (%) 5 (8)
Data are presented as the mean +/- standard deviation (SD) or number (%) when appropriate.
SAPS II: Simplified Acute Physiology Score type II. APACHE II: Acute Physiology And Chronic Health Evaluation II. CPR: Cardipulmonary 
Resuscitation
#5 unknown, 3 hangings, 1 anaphylactic shock, 1 hypothermia, 1 hyperkaliemia
Profile of the study Figure 1
Profile of the study.BMC Cardiovascular Disorders 2008, 8:35 http://www.biomedcentral.com/1471-2261/8/35
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tivity and specificity accurately predicted an unfavorable
outcome in 9/19 (47%) patients, but failed in two.
Discussion
Anoxic coma following cardiac arrest is a common prob-
lem with great ethical, social, and legal consequences. To
our knowledge, except for unfavorable SSEP results, pre-
dictors of unfavorable outcome with a 100% specificity
and a high sensitivity are lacking [1,11]. We have identi-
fied an early clinical and electrophysiological score that
has 100% predictive value of unfavorable result of SSEPs.
In addition, we complemented this result with a score pre-
dictive of a poor neurological outcome (death or vegeta-
tive state) in more than two-thirds of patients, with a low
false positive rate (4%) at day three. These results may
have important implications in determining the level of
care to be provided three days after cardiac arrest, if SSEPs
cannot be performed.
SSEPs are considered as the most accurate predictor of an
unfavorable outcome in survivors after a cardiac arrest
[1,5,8,12-17]. SSEP assessment is superior to clinical or
EEG tests in terms of low false positive rates and high
prevalence of abnormal test results [8], and the results of
SSEP assessment are less affected by metabolic changes
and sedative drugs than are clinical features and EEG read-
ings [26,27]. In addition, SSEPs can be used in patients
treated with hypothermia [16,28,29].
Our study confirmed the poor likelihood of awakening in
patients who remained comatose after cardiac arrest, as
80% of our patients never regained consciousness. This
result is consistent with results of previous studies that
included only patients who remained unconscious 24
hours after cardiac arrest [2,3,5,8,17,30].
We found that 51% of patients had no early cortical
responses to SSEPs, in agreement with previous reports
[5,8,17,30]. Furthermore, the presence of early cortical
responses to SSEPs was a poor predictor of a favorable
outcome as previously reported [4,5,8]; indeed, only 40%
(13/32) of our patients with a favorable result of SSEPs
made a good recovery.
Because the results of SSEPs demonstrate 100% specificity
as a predictor of poor outcome in half of patients in coma
patients after a cardiac arrest [1,5,8,12-17], we wanted to
identify predictors of unfavorable SSEP result as potential
substitutes for SSEPs, in settings without access to SSEPs.
At day three, we identified a score (≥ 88.5 points) based
on factors that were independently associated with an
unfavorable SSEP results (Table 2) with 100% positive
predictive value but low sensitivity (18%). In clinical prac-
tice, this score could allow early identification of a sub-
group of irrecoverable patients for whom continued
intensive care could be considered futile. In contrast, the
scores with the highest specificity and sensitivity at days
one and three could allow early identification of a large
Table 2: Results of univariate and multivariate analysis to define predictors of bilateral absence of early cortical responses to SSEPs 
(group 1) at day 1 and day 3.
n = 66 Univariate analysis Multivariate analysis
OR 95% CI* p value Beta** OR 95% CI* p-value
Day-1
Bilateral absence of corneal reflex 6.2 [2.0–19.0] 0.001 1.0 2.7 [0.7–11.0] 0.159
Bilateral absence of pupillary light reflex 9.3 [1.9–45.5] 0.006 - - - -
Presence of myoclonus 22.5 [6.0–83.8] <0.001 3.0 20.2 [4.8–84.7] <0.001
Tonic-clonic seizure 1.2 [0.3–4.9] 0.794 - - - -
Presence of malignant EEG 3.4 [0.8–14.4] 0.090 - - - -
Extensor or absent motor responses to pain 5.4 [1.3–21.8] 0.017 1.7 5.6 [0.9–32.8] 0.055
Day-3
Bilateral absence of corneal reflex 9.9 [3.0–32.4] <0.001 1.4 4.1 [0.8–20.9] 0.088
Bilateral absence of pupillary light reflex 21.7 [2.6–178.1] 0.004 2.1 7.8 [0.7–89.0] 0.097
Presence of myoclonus 7.9 [2.3–27.4] 0.001 2.5 11.7 [2.0–68.3] 0.006
Tonic-clonic seizure 0.2 [0.0–1.5] 0.108 - - - -
Presence of malignant EEG 6.6 [1.9–23.2] 0.003 1.1 3.1 [0.6–16.2] 0.183
Extensor or absent motor responses to pain 22.6 [2.7–186.4] 0.004 2.8 17.3 [1.1–210.0] 0.025
* CI: Confidence Interval; ** Beta denotes the estimated coefficient in the multivariate logistic regression model which predicted poor SSEPs results. 
The score related to each item is calculated as follows: points = beta × 10, according to Sullivan et al. [25]BMC Cardiovascular Disorders 2008, 8:35 http://www.biomedcentral.com/1471-2261/8/35
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Receiver operating characteristic curves at day 1 (2a) and day 3 (2b) of prediction models for bilateral absence of early cortical  responses to SSEPs Figure 2
Receiver operating characteristic curves at day 1 (2a) and day 3 (2b) of prediction models for bilateral absence 
of early cortical responses to SSEPs. (2a) The prediction model was based on following predictors at day 1: myoclonus, 
extensor or absent motor responses to pain and absence of corneal reflex. (2b) The prediction model was based on following 
predictors at day 3: extensor or absent motor responses to pain, myoclonus, absence of pupillary and corneal reflexes and a 
malignant EEG.BMC Cardiovascular Disorders 2008, 8:35 http://www.biomedcentral.com/1471-2261/8/35
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fraction of patients with unfavorable SSEPs results. How-
ever, the high false positive rate of these scores limits their
use as potential substitutes for SSEPs, particularly when
considering early withdrawal of intensive treatment.
Regarding poor neurological outcome, the score (Table 2)
at day one and day three predicted death or vegetative
state with 100% of specificity in one-quarter of our
patients, suggesting that a definitive pejorative prognosis
could be established early in a subset of patients for
whom intensive treatment could be withdrawn. These
scores combining simple clinical signs and EEG patterns,
had a lower sensitivity than an unfavourable result of
SSEPs alone. However, in patients with a favourable result
of SSEPs, this scoring system could help in the identifica-
tion of a subgroup of irrevocable patients.
However, the retrospective, single-center design of this
study and the relatively small number of patients studied
could limit the interpretation and the clinical relevance of
our data. Another aspect that could limit the applicability
of these data is that early withdrawal of treatment for
patients with poor prognoses could result in a self-fulfill-
ing prophesy of poor outcome. However, all of our
patients were actively supported at least until SSEPs were
assessed, and only a lack of bilateral cortical responses to
SSEPs led to active care withdrawal.
Conclusion
We developed a scoring system based on a combination of
early clinical and EEG factors that predicts with certainty
an unfavorable result of SSEPs or a poor neurological out-
come with a great accuracy in a subset of comatose survi-
vors after a cardiac arrest. This scoring system had a lower
sensitivity than an unfavourable result of SSEPs alone to
predict death or vegetative state. However, this scoring
system could assist clinicians, in settings without access
SSEPs or when an early cortical response (N20) to SSEPs
is present, in the early identification of a subgroup of irre-
coverable patients for whom intensive treatment could be
regarded futile and only palliative care could be given.
This strategy needs to be confirmed by larger prospective
trials.
Abbreviations
EEG: Electro-Encephalography; GP-CPC: Glasgow-Pitts-
burgh Cerebral Performance Category; NSE: Neuron-Spe-
cific Enolase; SSEPs: Somatosensory Evoked Potentials;
ROC: Receiver Operating Characteristics; Se: Sensitivity;
Sp: Specificity; PPV: Predictive Positive Value.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
CD and DG initiated the study, and the design. OE
reviewed all EEGs and SSEPs. JJP, CG and CD performed
Receiver operating characteristic curve of prediction models  for unfavorable outcome at day 1 (3a) and day 3 (3b) Figure 3
Receiver operating characteristic curve of prediction 
models for unfavorable outcome at day 1 (3a) and 
day 3 (3b). (3a) The prediction model was based on follow-
ing predictors at day 1: myoclonus, extensor or absent 
motor responses to pain and absence of corneal reflex. (3b) 
The prediction model was based on following predictors at 
day 3: extensor or absent motor responses to pain, myo-
clonus, absence of pupillary and corneal reflexes and a malig-
nant EEG.BMC Cardiovascular Disorders 2008, 8:35 http://www.biomedcentral.com/1471-2261/8/35
Page 8 of 9
(page number not for citation purposes)
the statistical analysis and were involved in the interpreta-
tion of the results. CD wrote the manuscript, and JJP and
PC helped to draft the manuscript. OE, DDC, MR, BB and
PC contributed to the conception and design of the study
and revision of the manuscript. All authors read and
approved the final manuscript.
Additional material
Acknowledgements
The authors want to thank Elisabeth Munoz Leconte, Patrick Chevrel, Max 
Courbier and Roger Viquelin for their valuable assistance.
Previous Presentation: The work has been presented in part at the annual 
congress of the Société de Réanimation de Langue Française (SRLF) held in 
January 2007, Paris, France.
References
1. Zandbergen EG, de Haan RJ, Stoutenbeek CP, Koelman JH, Hijdra A:
Systematic review of early prediction of poor outcome in
anoxic-ischaemic coma.  Lancet 1998, 352:1808-12.
2. Levy DE, Caronna JJ, Singer BH, Lapinski RH, Frydman H, Plum F:
Predicting outcome from hypoxic-ischemic coma.  JAMA
1985, 253:1420-6.
3. Edgren E, Hedstrand U, Kelsey S, Sutton-Tyrrell K, Safar P: Assess-
ment of neurological prognosis in comatose survivors of car-
diac arrest. BRCT I Study Group.  Lancet 1994, 343:1055-9.
4. Madl C, Grimm G, Kramer L, Yeganehfar W, Sterz F, Schneider B,
Kranz A, Schneeweiss B, Lenz K: Early prediction of individual
Additional file 1
EEG pattern according to the classification system of Synek [20,21]. 
The data provided represent the EEG pattern according to the classifica-
tion system of Synek.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2261-8-35-S1.doc]
Additional file 2
Neurological outcome according to the Glasgow-Pittsburgh Cerebral 
Performance Category (GP-CPC) [22]. The data provided represent the 
five grades Glasgow-Pittsburgh Cerebral performance category (GP-CPC) 
scale
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2261-8-35-S2.doc]
Contribution of scoring system to predict a poor neurological outcome regarding SSEPs access Figure 4
Contribution of scoring system to predict a poor neurological outcome regarding SSEPs access. * Sp: Specificity. 
Se: Sensitivity.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Cardiovascular Disorders 2008, 8:35 http://www.biomedcentral.com/1471-2261/8/35
Page 9 of 9
(page number not for citation purposes)
outcome after cardiopulmonary resuscitation.  Lancet 1993,
341:855-8.
5. Chen R, Bolton CF, Young B: Prediction of outcome in patients
with anoxic coma: a clinical and electrophysiologic study.  Crit
Care Med 1996, 24:672-8.
6. Wijdicks EF, Parisi JE, Sharbrough FW: Prognostic value of myo-
clonus status in comatose survivors of cardiac arrest.  Ann
Neurol 1994, 35(2):239-243.
7. Thomke F, Marx JJ, Sauer O, Hundsberger T, Hâgele S, Wiechelt J,
Weilemann SL: Observations on comatose survivors of cardi-
opulmonary resuscitation with generalized myoclonus.  BMC
Neurology 2005, 5:14.
8. Zandbergen EG, Hijdra A, Koelman JH, Hart AA, Vos PE, Verbeek
MM, de Haan RJ, PROPAC Study Group: Prediction of poor out-
come within the first 3 days of postanoxic coma.  Neurology
2006, 66:62-8.
9. Edgren E, Hedstrand U, Nordin M, Rydin E, Ronquist G: Prediction
of outcome after cardiac arrest.  Crit Care Med 1987, 15:820-5.
10. Bassetti C, Bomio F, Mathis J, Hess CW: Early prognosis in coma
after cardiac arrest: a prospective clinical, electrophysiolog-
ical, and biochemical study of 60 patients.  J Neurol Neurosurg
Psychiatr 1996, 61:610-5.
11. Wijdicks EF, Hijdra A, Young GB, Bassetti CL, Wiebe S, Quality
Standards Subcommittee of the American Academy of Neurology:
Practice parameter: prediction of outcome in comatose sur-
vivors after cardiopulmonary resuscitation (an evidence-
based review): report of the Quality Standards Subcommit-
tee of the American Academy of Neurology.  Neurology 2006,
67:203-10.
12. Madl C, Kramer L, Domanovits H, Woolard RH, Gervais H, Gendo
A, Eisenhuber E, Grimm G, Sterz F: Improved outcome predic-
tion in unconscious cardiac arrest survivors with sensory
evoked potentials compared with clinical assessment.  Crit
Care Med 2000, 28:721-6.
13. Nakabayashi M, Kurokawa A, Yamamoto Y: Immediate prediction
of recovery of consciousness after cardiac arrest.  Intensive
Care Med 2001, 27:1210-4.
14. Zingler VC, Krumm B, Bertsch T, Fassbender K, Pohlmann-Eden B:
Early prediction of neurological outcome after cardiopulmo-
nary resuscitation: a multimodal approach combining neuro-
biochemical and electrophysiological investigations may
provide high prognostic certainty in patients after cardiac
arrest.  Eur Neurol 2003, 49:79-84.
15. Robinson LR, Micklesen PJ, Tirschwell DL, Lew HL: Predictive
value of somatosensory evoked potentials for awakening
from coma.  Crit Care Med 2003, 31:960-7.
16. Tiainen M, Kovala TT, Takkunen OS, Roine RO: Somatosensory
and brainstem auditory evoked potentials in cardiac arrest
patients treated with hypothermia.  Crit Care Med 2005,
33:1736-40.
17. Fischer C, Luauté J, Némoz C, Morlet D, Kirkorian G, Mauguière F:
Improved prediction of awakening or nonawakening from
severe anoxic coma using tree-based classification analysis.
Crit Care Med 2006, 34:1520-4.
18. Le Gall JR, Lemeshow S, Saulnier F: A new Simplified Acute Phys-
iology Score (SAPS II) based on a European/North Ameri-
can multicenter study.  JAMA 1993, 270:2957-63.
19. Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: a
severity of disease classification system.  Crit Care Med 1985,
13:818-29.
20. Synek VM: EEG abnormality grades and subdivisions of prog-
nostic importance in traumatic and anoxic coma in adults.
Clin Electroencephalogr 1988, 19:160-6.
21. Synek VM: Prognostically important EEG coma patterns in
diffuse anoxic and traumatic encephalopathies in adults.  J
Clin Neurophysiol 1988, 5:161-74.
22. Cummins RO, Chamberlain DA, Abramson NS, Allen M, Baskett P,
Becker L, Bossaert L, Delooz H, Dick W, Eisenberg M: Recom-
mended guidelines for uniform reporting of data from out-
of-hospital cardiac arrest: the Utstein Style. Task Force of
the American Heart Association, the European Resuscita-
tion Council, the Heart and Stroke Foundation of Canada,
and the Australian Resuscitation Council.  Ann Emerg Med 1991,
20:861-74.
23. Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge
G, Smith K: Treatment of comatose survivors of out-of-hospi-
tal cardiac arrest with induced hypothermia.  N Engl J Med
2002, 346:557-63.
24. Hypothermia after Cardiac Arrest Study Group: Mild therapeutic
hypothermia to improve the neurologic outcome after car-
diac arrest.  N Engl J Med 2002, 346:549-56.
25. Sullivan LM, et al.: Presentation of multivariate data for clinical
use: The Framingham Study risk score functions.  Stat Med
2004, 23:1631-1660.
26. Koht A, Schatz W, Schmidt G, Schramm J, Watanabe E: Effects of
etomidate, midazolam, and thiopental on median nerve
somatosensory evoked potentials and the additive effects of
fentanyl and nitrous oxide.  Anesth Analg 1988, 67:435-41.
27. Sloan TB, Fugina ML, Toleikis JR: Effects of midazolam on median
nerve somatosensory evoked potentials.  Br J Anaesth 1990,
64:590-3.
28. Stecker MM, Cheung AT, Pochettino A, Kent GP, Patterson T, Weiss
SJ, Bavaria JE: Deep hypothermic circulatory arrest: I. Effects
of cooling on electroencephalogram and evoked potentials.
Ann Thorac Surg 2001, 71:14-21.
29. Kottenberg-Assenmacher E, Armbruster W, Bornfeld N, Peters J:
Hypothermia does not alter somatosensory evoked poten-
tial amplitude and global cerebral oxygen extraction during
marked sodium nitroprusside-induced arterial hypotension.
Anesthesiology 2003, 98:1112-8.
30. Jorgensen EO, Holm S: The natural course of neurological
recovery following cardiopulmonary.  Resuscitation 1998,
36:111-22.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2261/8/35/prepub